SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $450 | -99.9% | 10,721 | -20.9% | 0.04% | -35.7% |
| Q3 2022 | $531,000 | -12.4% | 13,557 | -27.7% | 0.07% | -23.1% |
| Q2 2022 | $606,000 | -45.3% | 18,750 | -28.0% | 0.09% | -34.5% |
| Q4 2021 | $1,108,000 | +198.7% | 26,035 | +211.0% | 0.14% | +265.8% |
| Q3 2021 | $371,000 | -62.4% | 8,371 | -51.8% | 0.04% | -65.8% |
| Q2 2021 | $987,000 | +75.9% | 17,381 | +167.9% | 0.11% | +20.7% |
| Q4 2020 | $561,000 | +93.4% | 6,487 | +36.7% | 0.09% | +91.7% |
| Q3 2020 | $290,000 | -52.8% | 4,744 | -77.8% | 0.05% | -68.8% |
| Q1 2020 | $614,000 | +38.0% | 21,374 | +246.6% | 0.15% | +196.2% |
| Q4 2019 | $445,000 | +8.8% | 6,167 | +10.1% | 0.05% | +225.0% |
| Q2 2015 | $409,000 | – | 5,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |